StonvexLoading…
StonvexStonvexStonvexCore line items from EVAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.53M | $3.34M | $73.00K | $0.00 |
Operating Income | $-9.23M | $-14.73M | $-22.20M | $-25.26M |
Net Income | $-7.71M | $-10.57M | $-22.13M | $-23.17M |
EPS (Diluted) | $-0.02 | $-0.20 | $-0.81 | $-0.98 |
Total Assets | $28.41M | $12.48M | $12.89M | $22.02M |
Total Liabilities | $11.37M | $14.14M | $17.62M | $13.72M |
Cash & Equivalents | $23.23M | $5.95M | $5.58M | $13.18M |
Free Cash Flow OCF − CapEx | $-6.64M | $-12.94M | $-17.78M | $-26.07M |
Shares Outstanding | 417.01M | Not available | Not available | Not available |